CEO Speaks about COVID Variants (Updated)

In this updated interview, LexaGene CEO, Dr. Jack Regan, speaks again about the company’s MiQLab and successfully detecting mutations of the virus. The MiQLab’s open-access nature makes it most suitable to rapidly identify new pathogens and strains at point-of-care. Watch now.